Brain protection using antegrade selective cerebral perfusion: a multicenter study

Marco Di Eusanio1, Marc A A M Schepens, Wim J Morshuis

  • 1Department of Cardiopulmonary Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands. m_dieus@hotmail.com

Insights

Antegrade selective cerebral perfusion shows encouraging results for brain protection during thoracic aortic surgery. This method did not impact hospital mortality or neurologic outcomes, regardless of replacement extent or perfusion duration.

Area of Science:

  • Cardiovascular Surgery
  • Neurosurgery
  • Thoracic Aortic Surgery

Background:

  • Antegrade selective cerebral perfusion (ASCP) is utilized for brain protection during thoracic aortic surgery.
  • Evaluating ASCP's efficacy and identifying predictors of mortality and neurologic complications is crucial.

Purpose of the Study:

  • To assess the outcomes of ASCP in thoracic aortic surgery.
  • To identify predictors of hospital mortality and adverse neurologic outcomes.

Main Methods:

  • A cohort of 588 patients undergoing aortic surgery with ASCP between 1995 and 2002.
  • Analysis included patient demographics, surgical techniques (e.g., separated graft, elephant trunk), and perfusion times.
  • Logistic regression was used to identify predictors of mortality and neurologic dysfunction.

Main Results:

  • Overall hospital mortality was 8.7%.
  • Predictors of mortality included urgent operation, recent neurologic event, tamponade, unplanned coronary revascularization, and pump time.
  • Permanent and transient neurologic dysfunction rates were 3.8% and 5.6%, respectively, with tamponade being a key predictor.

Conclusions:

  • ASCP demonstrated encouraging results in reducing hospital mortality and brain complications.
  • The extent of aortic replacement and duration of cerebral perfusion did not significantly influence mortality or neurologic outcomes.
Abstract

Related Concept Videos